The Third Reader - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Third Reader

If the pathology report is our work, then making sure the patient can understand what we have said is part of our work as well

  • By

  • Kamran Mirza

  • September 8, 2026

  • 13 min

Share

Clinical Report: The Third Reader

Overview

A study highlights significant disparities in patient understanding of prostate biopsy reports, with 39% correctly identifying cancer in standard reports compared to 93% in patient-centered versions.

Background

The accessibility of pathology reports to patients has increased dramatically since the implementation of the 21st Century Cures Act in April 2021. This change has led to patients encountering complex medical terminology without adequate support.

Data Highlights

Report TypeCorrect Cancer Identification
Standard Report39%
Patient-Centered Report93%

Key Findings

  • 39% of patients understood cancer presence in standard biopsy reports.
  • 93% of patients understood cancer presence in patient-centered reports.
  • 7% of patients learned their diagnosis through electronic portals.
  • 71% of patients who learned their diagnosis online were at home and alone.
  • 56% of AI users lack confidence in chatbot health information accuracy.

Clinical Implications

Healthcare providers should consider the implications of direct patient access to pathology reports.

Conclusion

The evolving landscape of patient access to medical information necessitates a reevaluation of how pathology reports are communicated.

Related Resources & Content

  1. JAMA, 2025 -- Study on Patient-Centered Pathology Reports
  2. NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026
  3. Current Cancer Protocols - CAP
  4. Eyecare Business — The Reader Rage
  5. Eyecare Business — ACCESSORIES CLOSE UP: READERS
  6. Eyecare Business — Reader Go-Round
  7. Optometric Management — reflections: Third-World Reminders
  8. The Reader Rage
  9. ACCESSORIES CLOSE UP: READERS
  10. Reader Go-Round
  11. Information Blocking - ONC - Office of the National Coordinator for Health Information Technology
  12. NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026 - PubMed
  13. Current Cancer Protocols - CAP

Original Source(s)

The Third Reader

  • by Kamran Mirza

  • September 8, 2026

Related Content

Estriol may ease menopause-related cognitive decline

Women reported improvement across 6 cognitive domains during 12 months of estriol-based treatment, while murine models suggested a potential astrocyte-mediated mechanism.

FDA approves serial liquid biopsy testing

In SERENA-6, patients who changed treatment following detection of an ESR1 mutation had a 56% lower risk of disease progression or death.

FDA expands essential thrombocythemia care

Phase 3 SURPASS ET data showed higher durable response rates with ropeginterferon alfa-2b-njft than with anagrelide.